Understanding overdose risks and treatment access for Medicare beneficiaries with disabilities.
Enhanced Assessment of Overdose Mortality, Other OUD-Related Outcomes, Treatment Access and Equity Among Medicare Beneficiaries with Disability, Across Racial/Ethnic Subgroups and Communities
['FUNDING_R01'] · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · NIH-11118026
This study looks at why some people with disabilities on Medicare are at higher risk of dying from opioid overdoses, especially focusing on differences among racial and ethnic groups, and aims to find ways to improve treatment access and reduce these tragic outcomes.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RUTGERS BIOMEDICAL AND HEALTH SCIENCES (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-11118026 on ClinicalTrials.gov |
What this research studies
This research investigates the factors contributing to fatal opioid overdoses among Medicare beneficiaries with disabilities, focusing on racial and ethnic disparities. By linking Medicare claims data with the National Death Index, the study aims to identify predictors of overdose risk and assess the effectiveness of treatment access. The approach involves analyzing comprehensive data to understand treatment histories and community factors that influence overdose outcomes. This research seeks to provide insights that can inform health system strategies to reduce overdose mortality.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicare beneficiaries with disabilities, particularly those from minoritized racial and ethnic communities.
Not a fit: Patients who do not have Medicare or do not have disabilities may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment access and reduced overdose mortality among vulnerable populations.
How similar studies have performed: Previous research has shown success in analyzing overdose risks and treatment access among Medicare beneficiaries, indicating that this approach has the potential for meaningful insights.
Where this research is happening
Newark, UNITED STATES
- RUTGERS BIOMEDICAL AND HEALTH SCIENCES — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CRYSTAL, STEPHEN — RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- Study coordinator: CRYSTAL, STEPHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.